Interestingly UBE2V1, RP11‐128N14.5, TGFB2/TGFB2‐OT1 were up‐regulated in severe NAFLD patient with respect to mild NAFLD and controls. The gene discussed is TGFB2; the disease is metabolic dysfunction-associated steatotic liver disease.